DE69927987D1 - Hemmung von mit gewebetrauma verbundenen pathogenen prozessen - Google Patents

Hemmung von mit gewebetrauma verbundenen pathogenen prozessen

Info

Publication number
DE69927987D1
DE69927987D1 DE69927987T DE69927987T DE69927987D1 DE 69927987 D1 DE69927987 D1 DE 69927987D1 DE 69927987 T DE69927987 T DE 69927987T DE 69927987 T DE69927987 T DE 69927987T DE 69927987 D1 DE69927987 D1 DE 69927987D1
Authority
DE
Germany
Prior art keywords
group
effector
pharmaceutically acceptable
tissue
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69927987T
Other languages
English (en)
Other versions
DE69927987T2 (de
Inventor
Mark Pines
Israel Vlodavsky
Arnon Nagler
Eli Hazum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hadasit Medical Research Services and Development Co
Agricultural Research Organization of Israel Ministry of Agriculture
Original Assignee
Hadasit Medical Research Services and Development Co
Agricultural Research Organization of Israel Ministry of Agriculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Medical Research Services and Development Co, Agricultural Research Organization of Israel Ministry of Agriculture filed Critical Hadasit Medical Research Services and Development Co
Application granted granted Critical
Publication of DE69927987D1 publication Critical patent/DE69927987D1/de
Publication of DE69927987T2 publication Critical patent/DE69927987T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69927987T 1998-08-13 1999-08-13 Hemmung von mit gewebetrauma verbundenen pathogenen prozessen Expired - Fee Related DE69927987T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IL12579098 1998-08-13
IL12579098 1998-08-13
US13714599P 1999-06-01 1999-06-01
US137145P 1999-06-01
PCT/IL1999/000440 WO2000009070A2 (en) 1998-08-13 1999-08-13 Inhibition of pathogenic processes related to tissue trauma

Publications (2)

Publication Number Publication Date
DE69927987D1 true DE69927987D1 (de) 2005-12-01
DE69927987T2 DE69927987T2 (de) 2006-11-09

Family

ID=26323693

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69927987T Expired - Fee Related DE69927987T2 (de) 1998-08-13 1999-08-13 Hemmung von mit gewebetrauma verbundenen pathogenen prozessen

Country Status (8)

Country Link
EP (1) EP1109559B1 (de)
JP (1) JP2002522462A (de)
AT (1) ATE307586T1 (de)
AU (1) AU756437B2 (de)
CA (1) CA2340176A1 (de)
DE (1) DE69927987T2 (de)
ES (1) ES2255286T3 (de)
WO (1) WO2000009070A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143366A0 (en) * 2001-05-24 2002-04-21 Harasit Medical Res Services & Treatment of renal fibrosis
EP1558261A4 (de) * 2002-10-31 2008-06-04 Israel State Chinazolinon-zusammensetzungen zurregulierung der genexpression im zusammenhang mit pathologischen prozessen
US20080025917A1 (en) * 2006-04-10 2008-01-31 Malcolm Whitman Methods for modulating formation and progression of cellulite
AU2008206643B2 (en) 2007-01-21 2013-09-19 Agricultural Research Organization Composition and method for treating or preventing skeletal muscle fibrosis
CA2737219C (en) 2008-08-11 2017-02-28 Tracy Keller Halofuginone analogs for inhibition of trna synthetases and uses thereof
JP5966227B2 (ja) 2011-02-10 2016-08-10 国立大学法人 長崎大学 急性肺損傷診断方法
AU2013207796B2 (en) 2012-01-13 2017-04-27 President And Fellows Of Harvard College Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions
US11708353B2 (en) 2018-06-08 2023-07-25 The General Hospital Corporation Inhibitors of prolyl-tRNA-synthetase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones
DE2934069A1 (de) * 1979-08-23 1981-03-12 Hoechst Ag, 6000 Frankfurt Mittel gegen theileriosen und seine verwendung.
DE69431433T2 (de) * 1993-05-07 2003-12-04 Solomon B Margolin Zusammensetzungen und verfahren zur reparatur und vorbeugung fibrotischer verletzungen
CA2113229C (en) * 1994-01-11 1999-04-20 Mark Pines Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
IL110831A (en) * 1994-08-31 1998-12-27 Hadasit Med Res Service Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis
JPH0971586A (ja) * 1995-09-07 1997-03-18 Yamanouchi Pharmaceut Co Ltd 新規な二環性縮合イミダゾール誘導体
AU3667397A (en) * 1996-07-03 1998-01-21 Alain Colige Recombinant n-proteinase, and the production, methods and uses thereof
CA2632790A1 (en) * 1996-07-22 1998-01-29 Renovo Limited Use of sex steroid function modulators to treat wounds and fibrotic disorders
PT941108E (pt) * 1996-12-04 2003-01-31 Renovo Ltd Cicatrizacao de feridas e tratamento da fibrose
US5852024A (en) * 1997-02-11 1998-12-22 Hadasit Treatment and prevention of adhesions
US6028075A (en) * 1997-02-11 2000-02-22 Pines; Mark Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
DE19951702A1 (de) * 1999-10-27 2001-05-03 Aventis Pharma Gmbh Verwendung von 2-Amino-3,4-dihydro-chinazolinen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten

Also Published As

Publication number Publication date
AU5191499A (en) 2000-03-06
AU756437B2 (en) 2003-01-16
EP1109559B1 (de) 2005-10-26
WO2000009070A2 (en) 2000-02-24
ATE307586T1 (de) 2005-11-15
CA2340176A1 (en) 2000-02-24
WO2000009070A3 (en) 2000-10-19
ES2255286T3 (es) 2006-06-16
DE69927987T2 (de) 2006-11-09
EP1109559A2 (de) 2001-06-27
EP1109559A4 (de) 2002-05-08
JP2002522462A (ja) 2002-07-23

Similar Documents

Publication Publication Date Title
BR0213129A (pt) Pró-drogas de compostos policìclicos substituìdos, úteis para inibição seletiva da cascata da coagulação
WO2001019798A3 (en) Inhibitors of factor xa
BRPI0409417A (pt) método para usar um composto, composto, e, composição
DK0682664T3 (da) Forbindelser med både potent calciumantagonist og antioxiderende aktivitet og anvendelse deraf som cytobeskyttende midler
TW369526B (en) Diazabicyclic neurokinin antagonists
ATE191143T1 (de) Verwendung von nichtsteroidalen cyclooxygenasehemmern zur herstellung eines medikaments zur behandlung vom erhoehten augeninnendruck
BR0008202A (pt) Derivados de quinolin-2-ona substituìdos com heteroarilas úteis como agentes contra o câncer
BR9811099A (pt) Inibidores de urocinase
CR7931A (es) 4-[(2,4-dicloro-5-metroxifenil)amino]-6-alkoxi-3- quinolincarbonitrilos para el tratamiento de lesiones isquemicas
NO304891B1 (no) Steroidderivater for behandling av prostatahypertrofi
DE60141520D1 (de) 5-asa-derivate mit entzündungshemmender und antibiotischer wirkung und verfahren zur behandlung von krankheiten mit diesen derivaten
ATE150301T1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische zusammensetzungen davon zur prävention oder behandlung von herzerkrankungen
DE69927987D1 (de) Hemmung von mit gewebetrauma verbundenen pathogenen prozessen
BG104717A (en) Water soluble azoles as broad-spectrum antifungals
DE69808099T2 (de) Substituierte 6-alkylphenanthridine
IL110831A0 (en) Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
KR970702273A (ko) 인돌 유도체 및 이를 함유하는 제제(indole derivative and medicine containing the same)
DE69232143T2 (de) Verwendung von Amlexanox zur Herstellung eines Arzneimittels zur Behandlung von aphtösen Ulcera
EP1418910A4 (de) Verfahren zur unterdrückung oder umkehrung der tau-filament-bildungspolymerisation
ES2099180T3 (es) Derivados del benzopirano y procedimientos para su preparacion.
ATE279925T1 (de) Verwendung von halofuginon zur herstellung eines medikaments zur vorbeugung von neovaskularisation und zur behandlung bösartiger tumore
DK1120415T3 (da) Substituerede isoxazolylthiophenforbindelser
DK0912568T3 (da) Imidazopyridiner
TW288015B (en) New chromene derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee